Contracts Finder · Award

Procurement of Pipettes, Base Units, etc

A public procurement published by Medicines Discovery Catapult via Contracts Finder.

Contracts FinderAward
£114k
Award value
£114k
Tender value
1
Suppliers
1
Awards
1
Notices
Award
Stage

Overview

Purchase of pipettes, base units and accessories related to the establishment of a Lighthouse laboratory as part of the UK Government response to the COVID-19 pandemic.

Key details

Source
Contracts Finder
Lifecycle stage
Award
Status
complete
CPV classification
38000000 — Laboratory, optical and precision equipments (excl. glasses)
Currency
GBP
Total award value
£114,000
Tender value
£114,000
First published
28 May 2020
Last updated
28 May 2020
View the original notice

Awards

1 award recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
INTEGRA Biosciences Limited0846282914 Apr 2020active£114k

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Award noticeProcurement of Pipettes, Base Units, etc

All suppliers

Frameworks & programmes

More from Medicines Discovery Catapult

FAQs about this procurement

Who is the buyer for "Procurement of Pipettes, Base Units, etc"?

Procurement of Pipettes, Base Units, etc is a UK public-sector procurement published by Medicines Discovery Catapult via Contracts Finder.

Has "Procurement of Pipettes, Base Units, etc" been awarded?

Yes — 1 award is recorded, with a reported total value of £114,000. The current lifecycle stage is "Award".

Which suppliers are involved in "Procurement of Pipettes, Base Units, etc"?

1 supplier is linked: INTEGRA Biosciences Limited.

What is "Procurement of Pipettes, Base Units, etc" worth?

The reported award value is £114,000.

When was "Procurement of Pipettes, Base Units, etc" published?

It was first published on 28 May 2020 and last updated on 28 May 2020, across 1 notice.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable